Married lung cancer patients survive longer than single patients after treatment

September 6, 2012

Married patients with locally advanced lung cancer are likely to survive longer after treatment than patients who are single, according to a study by researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center in Baltimore. The results of the retrospective study are being presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.

The University of Maryland researchers studied 168 with Stage III non-small cell , the most common type of lung , who were treated with chemotherapy and radiation over a 10-year-period, from January 2000 and December 2010. They found that 33 percent of married patients were still alive after three years compared to 10 percent of the single patients, with women faring better than men. Married women had the best three-year survival rate (46 percent), and single men had the worst rate (3 percent). Single women and married men had the same 25 survival rate at three years. White married patients had a better survival rate than married African-Americans.

"Marital status appears to be an important of survival in patients with locally advanced non-small cell lung cancer," says the study's lead author, Elizabeth Nichols, M.D., a resident at the University of Maryland Greenebaum Cancer Center. "The reason for this is unclear, but our findings suggest the importance of social support in managing and treating our . Patients may need help with day-to-day activities, getting to treatment and making sure they receive proper follow-up care."

"We believe that better supportive care and support mechanisms for cancer patients can have a greater impact on increasing survival than many new techniques. Not only do we need to continue to focus on finding and cancer therapies, but also on ways to better support our cancer patients," says Dr. Nichols, who collaborated on the study with senior faculty at the University of Maryland School of Medicine.

The study's senior author, Steven J. Feigenberg, M.D., an associate professor of radiation oncology at the School of Medicine, says additional research is planned. "We need to better understand why marriage is a factor in our patients' survival," says Dr. Feigenberg, who is also a radiation oncologist at the University of Maryland Greenebaum Cancer Center. "We're also trying to determine if these findings can be corroborated in the multi-institutional setting,"

E. Albert Reece, M.D., Ph.D., M.B.A., vice president for medical affairs at the University of Maryland and the John Z. and Akiko K. Bowers Distinguished Professor and dean of the University of Maryland School of Medicine, says, "Lung cancer is the No. 1 cause of cancer death in both men and women, and this study by researchers at the University of Maryland School of Medicine suggests that having a spouse who can act as a caregiver may improve survival for patients with this type of cancer. We must figure out ways to help all of our cancer patients live longer, with a better quality of life, regardless of their marital status."

The patients in the study were evaluated by a multidisciplinary team of radiation oncologists, surgeons and medical oncologists at the Greenebaum and were treated with a standard combination of radiation and chemotherapy, typically followed by additional rounds of chemotherapy. With a mean follow-up of a year and four months, the mean survival was 13 months. Researchers used an analysis tool to estimate overall survival, with 21 percent of the patients alive at three years and 12 percent at five years.

Previous studies have found decreased survival for single men diagnosed with several types of cancer, including prostate and head-and-neck cancers. A study of 440,000 Norwegian men and women, published last year, found that men who never married were 35 percent more likely to die from cancer than married men. Never-married women were 22 percent more likely to die of cancer than those who were married. The study looked at deaths from 13 common cancers.

Explore further: Young women with early breast cancer have similar survival with breast conservation, mastectomy

Related Stories

Young women with early breast cancer have similar survival with breast conservation, mastectomy

September 7, 2011
Young women with early-stage breast cancer have similar survival rates with a lumpectomy and radiation treatment, known as breast-conservation therapy, as with mastectomy, a new study conducted at the University of Maryland ...

'Never married' men still more likely to die from cancer

October 14, 2011
It is known that the unmarried are in general more likely to die than their married counterparts and there is some indication that the divide is in fact getting worse. New research published in BioMed Central's open access ...

Many lung cancer patients get radiation therapy that may not prolong their lives

February 13, 2012
A new study has found that many older lung cancer patients get treatments that may not help them live longer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest ...

Standard treatments for head and neck cancer less effective in HIV-positive patients

January 26, 2012
Radiation therapy with or without chemotherapy is less effective for patients with HIV when compared to the recurrence and overall survival rates in patients who do not have HIV, according to a study presented at the Multidisciplinary ...

SBRT provides better outcomes than surgery for cancer patients with common lung disease

February 16, 2012
Stereotactic body radiotherapy (SBRT) provides better overall survival rates than surgery for lung cancer patients with severe chronic obstructive pulmonary disease (COPD), a disease commonly associated with lung cancer, ...

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.